164 related articles for article (PubMed ID: 27174320)
1. Aberrant Alternative Polyadenylation is Responsible for Survivin Up-regulation in Ovarian Cancer.
He XJ; Zhang Q; Ma LP; Li N; Chang XH; Zhang YJ
Chin Med J (Engl); 2016 May; 129(10):1140-6. PubMed ID: 27174320
[TBL] [Abstract][Full Text] [Related]
2. Shortening of the 3' untranslated region: an important mechanism leading to overexpression of HMGA2 in serous ovarian cancer.
He X; Yang J; Zhang Q; Cui H; Zhang Y
Chin Med J (Engl); 2014; 127(3):494-9. PubMed ID: 24451956
[TBL] [Abstract][Full Text] [Related]
3. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
[TBL] [Abstract][Full Text] [Related]
5. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of alternative polyadenylation in human preimplantation embryos.
Chang JY; Yu WH; Juan HF; Huang HC
Biochem Biophys Res Commun; 2018 Oct; 504(4):727-733. PubMed ID: 30217451
[TBL] [Abstract][Full Text] [Related]
7. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
8. Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation.
Bruhn O; Lindsay M; Wiebel F; Kaehler M; Nagel I; Böhm R; Röder C; Cascorbi I
Mol Pharmacol; 2020 Feb; 97(2):112-122. PubMed ID: 31757862
[TBL] [Abstract][Full Text] [Related]
9. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
[TBL] [Abstract][Full Text] [Related]
10. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
11. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
12. Targeted Microbubbles for Ultrasound Mediated Short Hairpin RNA Plasmid Transfection to Inhibit Survivin Gene Expression and Induce Apoptosis of Ovarian Cancer A2780/DDP Cells.
Zhang Y; Chang S; Sun J; Zhu S; Pu C; Li Y; Zhu Y; Wang Z; Xu RX
Mol Pharm; 2015 Sep; 12(9):3137-45. PubMed ID: 26212628
[TBL] [Abstract][Full Text] [Related]
13. Detecting alternative polyadenylation from microarray data.
Lembo A; Provero P
Methods Mol Biol; 2014; 1125():141-4. PubMed ID: 24590786
[TBL] [Abstract][Full Text] [Related]
14. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
15. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway.
Alajez NM; Lenarduzzi M; Ito E; Hui AB; Shi W; Bruce J; Yue S; Huang SH; Xu W; Waldron J; O'Sullivan B; Liu FF
Cancer Res; 2011 Mar; 71(6):2381-91. PubMed ID: 21385904
[TBL] [Abstract][Full Text] [Related]
16. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
Kim N; Chung W; Eum HH; Lee HO; Park WY
PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
[TBL] [Abstract][Full Text] [Related]
17. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites.
Lee I; Ajay SS; Yook JI; Kim HS; Hong SH; Kim NH; Dhanasekaran SM; Chinnaiyan AM; Athey BD
Genome Res; 2009 Jul; 19(7):1175-83. PubMed ID: 19336450
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
Zhang X; Huang L; Zhao Y; Tan W
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
[TBL] [Abstract][Full Text] [Related]
19. Alternative Polyadenylation in Triple-Negative Breast Tumors Allows NRAS and c-JUN to Bypass PUMILIO Posttranscriptional Regulation.
Miles WO; Lembo A; Volorio A; Brachtel E; Tian B; Sgroi D; Provero P; Dyson N
Cancer Res; 2016 Dec; 76(24):7231-7241. PubMed ID: 27758885
[TBL] [Abstract][Full Text] [Related]
20. Tempo-spatial alternative polyadenylation analysis reveals that 3' UTR lengthening of Mdm2 regulates p53 expression and cellular senescence in aged rat testis.
Wang L; Chen M; Fu H; Ni T; Wei G
Biochem Biophys Res Commun; 2020 Mar; 523(4):1046-1052. PubMed ID: 31973811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
